Charles River Laboratories International Inc (NYSE:CRL)
$ 214.2 25.52 (13.53%) Market Cap: 10.95 Bil Enterprise Value: 13.50 Bil PE Ratio: 25.59 PB Ratio: 2.97 GF Score: 87/100

Charles River Laboratories International Inc at Jefferies London Healthcare Conference (Virtual) - Pre-Recorded Transcript

Nov 18, 2021 / 08:00AM GMT
Release Date Price: $387.51 (-1.42%)
David Howard Windley
Jefferies LLC, Research Division - MD & Equity Analyst

Hi, everybody. Welcome to Jefferies London Healthcare Conference here in November. We are, this year, kind of moving one step toward being open. We split the conference into an in-person portion of the conference, which was Tuesday. Hope I have the day's right, Tuesday, the 16th and Wednesday, the 17th. And so the 18th and 19th, Thursday and Friday, are virtual.

This is part of the virtual session. We appreciate your interest in clicking on to this on-demand video by the time it is posted. And our discussion with Charles River Laboratories. I'm Dave Windley. I'm in Jefferies Healthcare Equity Research based in the states and cover the pharmaceutical services and CRO space, of which Charles River is a leading player, in which they are a leading player.

Here to talk with me about Charles River's business is David Smith, the company's Chief Financial Officer. So welcome, David, and thank you for your attendance. Sorry, we couldn't have dinner in London this year, but we'll have to hope for that next year.

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot